PNPLA3 and metabolic dysfunction-associated steatotic liver disease: It has also been shown by others that the GCKR variant associates with dyslipidemia, while this is not the case for many other NAFLD risk-increasing genotypes such as PNPLA3 [6, 60] and that it increases the risk of NAFLD in obese individuals [58].